{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:48:16Z","timestamp":1757314096408,"version":"3.38.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1002\/jps.22720","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T20:12:58Z","timestamp":1313611978000},"page":"5315-5323","source":"Crossref","is-referenced-by-count":6,"title":["Ocular Pharmacokinetics of a Novel Tetrahydroquinoline Analog in Rabbit: Absorption, Disposition, and Non-compartmental Analysis"],"prefix":"10.1016","volume":"100","author":[{"given":"Chandrasena R.","family":"Pamulapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald D.","family":"Schoenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22720_bb0005","series-title":"Pharmacology of the eye","first-page":"19","article-title":"Ocular pharmacokinetics","author":"Maurice","year":"1984"},{"key":"10.1002\/jps.22720_bb0010","series-title":"Controlled drug bioavailability","first-page":"257","article-title":"The control of drug bioavailability from ophthalmic dosage forms","author":"Schoenwald","year":"1985"},{"key":"10.1002\/jps.22720_bb0015","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archopht.1988.01060140266039","article-title":"Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors","volume":"106","author":"Edelhauser","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.22720_bb0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jps.2600760802","article-title":"Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea","volume":"76","author":"Ahmed","year":"1987","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22720_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(86)90024-4","article-title":"Selective intraocular delivery of liposome encapsulated inulin via the non-corneal absorption route","volume":"34","author":"Ahmed","year":"1986","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22720_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0002-9394(14)77735-9","article-title":"Penetration routes of topically applied eye medications","volume":"85","author":"Doane","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"10.1002\/jps.22720_bb0035","unstructured":"Hitoshi S, Bundgaard H, Lee VH. 1989. Design of prodrugs to selectively reduce timolol absorption on the basis of the7. differential lipophilic characteristics of the cornea and the conjunctiva. Invest Ophthalmol Vis Sci Suppl 30:S25."},{"key":"10.1002\/jps.22720_bb0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/jop.1992.8.247","article-title":"Biopharmaceutical explanation for the topical activity of 6-hydroxyethoxy-2- benzothiazole-sulfonamide in the rabbit eye","volume":"8","author":"Lee","year":"1992","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.22720_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archopht.1978.03910050487020","article-title":"Soluble gentamicin ophthalmic inserts as a drug delivery system","volume":"96","author":"Bloomfield","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.22720_bb0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/02713688109001870","article-title":"The penetration of exogenous prostaglandin and arachidonic acid into, and their distribution within, the mammalian eye","volume":"1","author":"Bito","year":"1982","journal-title":"Curr Eye Res"},{"key":"10.1002\/jps.22720_bb0055","first-page":"584","article-title":"Importance of the noncorneal absorption route in topical ophthalmic drug delivery","volume":"26","author":"Ahmed","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.22720_bb0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003088-199018040-00001","article-title":"Ocular drug delivery","volume":"18","author":"Schoenwald","year":"1990","journal-title":"Pharmacokinetic considerations. Clin Pharmacokinet"},{"key":"10.1002\/jps.22720_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jop.1986.2.67","article-title":"Topical ocular drug delivery: Recent developments and future challenges","volume":"2","author":"Lee","year":"1986","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.22720_bb0070","series-title":"Havener's ocular pharmacology","first-page":"22","article-title":"Pharmacokinetics","author":"DeSantis","year":"1994"},{"key":"10.1002\/jps.22720_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jop.1986.2.345","article-title":"Metabolic and permeation barriers to the ocular absorption of topically applied enkephalins in albino rabbits","volume":"2","author":"Lee","year":"1986","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.22720_bb0080","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3109\/02713688509003358","article-title":"Ocular esterase composition in albino and pigmented rabbits: Possible implications in ocular prodrug design and evaluation","volume":"4","author":"Lee","year":"1985","journal-title":"Curr Eye Res"},{"key":"10.1002\/jps.22720_bb0085","first-page":"315","article-title":"Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine","volume":"17","author":"Wei","year":"1978","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.22720_bb0090","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0022-3565(25)22204-2","article-title":"Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit","volume":"246","author":"Lee","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.22720_bb0095","article-title":"Tetrahydroquinoline analogues for use in glaucoma treatment","volume":"5776482","author":"Schoenwald","year":"1998","journal-title":"Patent US"},{"key":"10.1002\/jps.22720_bb0100","doi-asserted-by":"crossref","unstructured":"Pamulapati CR, Schoenwald RD. 2011. Ocular hypotensive action of a novel tetrahydroquinoline analog in rabbit: Physicochemical evaluation. J Pharm Sci (in press).","DOI":"10.1002\/jps.22717"},{"key":"10.1002\/jps.22720_bb0105","doi-asserted-by":"crossref","unstructured":"Pamulapati CR, Schoenwald RD. 2011. Ocular pharmacokinetics of a novel tetrahydroquinoline analog in rabbit: Com- partmental analysis and PK\/PD evaluation. J Pharm Sci (submitted for publication).","DOI":"10.1002\/jps.22764"},{"key":"10.1002\/jps.22720_bb0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jps.2600740506","article-title":"Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors","volume":"74","author":"Eller","year":"1985","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22720_bb0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01062463","article-title":"Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye","volume":"20","author":"Rao","year":"1992","journal-title":"J Pharmcokinet Bio- pharm"},{"key":"10.1002\/jps.22720_bb0120","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/jop.2000.16.481","article-title":"The ocular pharmacokinetics of ketanserin and its metabolite, ketanserinol, in albino rabbits","volume":"16","author":"Schoenwald","year":"2000","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1002\/jps.22720_bb0125","series-title":"Ophthalmic drug delivery systems","first-page":"135","article-title":"Ocular pharmacokinetics and pharmacodynamics","author":"Schoenwald","year":"2003"},{"key":"10.1002\/jps.22720_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/jop.1997.13.41","article-title":"Penetration into the anterior chamber via the con- junctival\/scleral pathway","volume":"13","author":"Schoenwald","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1002\/jps.22720_bb0135","series-title":"In Biopharmaceutics of ocular drug delivery","first-page":"176","article-title":"Pharmacokinetics in ocular drug delivery. In Biopharmaceutics of ocular drug delivery; Edman P","author":"Schoenwald","year":"1993"},{"key":"10.1002\/jps.22720_bb0140","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/bod.2510090603","article-title":"Ocular absorption and disposition of phenylephrine and phenylephrine oxazolidine","volume":"9","author":"Schoenwald","year":"1988","journal-title":"Bio- pharm Drug Dispos"},{"key":"10.1002\/jps.22720_bb0145","unstructured":"Ing IS. 1986. N-methylacetazolamide ocular disposition and enzyme kinetics. Ph.D. Thesis. Iowa City: The University of Iowa."},{"key":"10.1002\/jps.22720_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01065260","article-title":"Ocular pharmacokinetic models of clonidine-3H hydrochloride","volume":"14","author":"Chiang","year":"1986","journal-title":"J Pharmacokinet Bio- pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915318232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915318232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T22:06:18Z","timestamp":1741471578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915318232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0022354915318232"],"URL":"https:\/\/doi.org\/10.1002\/jps.22720","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}